Efficacy of Directly Observed Treatment of HIV Infection: Experience in AIDS Welfare Homes

Tinoco, I.; Girón-González, J. A.; González-González, M. T.; Vergara de Campos, A.; Rodriguez-Felix, L.; Serrano, A.; Bascuñana, A.
April 2004
European Journal of Clinical Microbiology & Infectious Diseases;Apr2004, Vol. 23 Issue 4, p331
Academic Journal
With the objective of analyzing the efficacy of directly observed treatment (DOT) of HIV infection in the management of severely immunodepressed patients, this method was examined in individuals cared for in two social welfare facilities for HIV-infected persons and compared to self-administered therapy in outpatients. Forty-seven patients with registered H IV infection, stage C, were assigned to DOT for 9 months, the majority of whom had previously received antiretroviral therapy. A group of 51 HIV-infected outpatients, who attended day clinics attached to the reference hospitals, served as a comparison group. Together with increases in weight (9.2 ±7.5 kg) and Karnofsky scores (16.9±12.2) in the DOT group, a significant improvement of surrogate markers, such as CD4+ T-cell counts (increase in DOT group, 113.4 ±151.0 cells/µl; control group, -2.8±114.1 cells/µl; P<0.001) and HIV load (decrease in DOT group, -1.7 ±2.3 log10 copies/ml; control group, -0.4±1.5 log10 copies/ml; P<0.01) was detected in the DOT group. Morbidity and mortality were similar in both groups. The results indicate that such welfare facilities provide a useful framework not only for social objectives but also for healthcare purposes.


Related Articles

  • Diplopia in a Patient with HIV Infection. Dhillon, Wishwdeep S.; Shah, Tushar // New England Journal of Medicine;4/15/2010, Vol. 362 Issue 15, pe52 

    The article presents a case study of a man with human immunodeficiency virus (HIV) infection who was receiving highly active antiretroviral therapy and found to have diplopia and headache for a week.

  • Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India. Tripathy, S.; Anand, A.; Inamdar, V.; Manoj, M. M.; Khillare, K. M.; Datye, A. S.; Iyer, R.; Kanoj, D. M.; Thakar, M.; Kale, V.; Pereira, M.; Risbud, A. R. // Indian Journal of Medical Research;May2011, Vol. 133 Issue 5, p521 

    Background & objectives: in the Revised National Tuberculosis Control Programme (RNTCP) in India prior to 2005, TB patients were offered standard DOTS regimens without knowledge of HIV status. Consequently such patients did not receive anti-retroviral therapy (ART) and the influence of...

  • Optimization of HAART with genetic algorithms and agent-based models of HIV infection. F. Castiglione; F. Pappalardo; M. Bernaschi; S. Motta // Bioinformatics;Dec2007, Vol. 23 Issue 24, p3350 

    Motivation: Highly Active AntiRetroviral Therapies (HAART) can prolong life significantly to people infected by HIV since, although unable to eradicate the virus, they are quite effective in maintaining control of the infection. However, since HAART have several undesirable side effects, it is...

  • Early drug therapy reduces HIV transmission, study says. Taylor, Billy // Pink Paper;5/13/2011, p1 

    The article offers information on the HIV Prevention Trials Network's controlled trial conducted across Africa, Asia and the Americas, known as HPTN 052, which shows that treating an HIV-positive person with anti-retroviral therapy can reduce the risk of sexual transmission of HIV to an...

  • Implementation and Effectiveness of Antiretroviral Therapy in Greenland. Lohse, Nicolai; Ladefoged, Karin; Obel, Niels // Emerging Infectious Diseases;Jan2008, Vol. 14 Issue 1, p56 

    Analyses from the Danish HIV Cohort Study showed that, despite comparable economic means and general education of healthcare personnel, antiretroviral treatment of HIV in Greenland began later and has been implemented at a slower pace with lower therapeutic effectiveness than in Denmark....

  • Antiretroviral therapy of late presenters with advanced HIV disease. Manuel Battegay; Jan Fehr; Ursula Flückiger; Luigia Elzi // Journal of Antimicrobial Chemotherapy (JAC);Jul2008, Vol. 62 Issue 1, p41 

    Potent antiretroviral therapy (ART) has dramatically improved the prognosis of HIV-1-infected individuals. However, 10% to 30% of patients in Western countries still present late for care, when CD4 T cells are below 200 cells/mm3 and symptomatic HIV disease has occurred. Clinical considerations...

  • Emtricitabine: An Antiretroviral Agent for HIV infection. Bang, Lynne M.; Scott, Lesley L. // Drugs;2003, Vol. 63 Issue 22, p2413 

    ▴ Emtricitabine, a nucleoside reverse transcriptase inhibitor, is phosphorylated by cellular enzymes to emtricitabine 5′-triphosphate which, in turn, inhibits the activity of HIV-1 (HIV) reverse transcriptase by competing with the endogenous substrate. Incorporation of the...

  • Standing in the Way of Eradication: HIV-1 Infection and Treatment in the Male Genital Tract. Shehu-Xhilaga, Miranda; De Kretser, David; Dejucq-Rainsford, Nathalie; Hedger, Mark // Current HIV Research;Oct2005, Vol. 3 Issue 4, p345 

    As a result of the introduction of the Highly Active Antiretroviral Therapy (HAART) many HIV-1 infected individuals are able to live an improved and extended life style that can include the prospect of having children. Problematically, the male reproductive organs may contribute infected cells...

  • Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa. Mills, Edward J.; Nabiryo, Christine // PLoS Medicine;Jan2013, Vol. 10 Issue 1, p1 

    An introduction is presented in which the editors discuss the article on the issue concerning the study which explores the antiretroviral treatment of patients with HIV and AIDS in Africa.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics